American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will release its first quarter 2026 financial results before the market opens on May 14, 2026. The company will hold a conference call the same day at 12:00 PM ET to discuss the results.
This announcement is significant for investors and the healthcare industry as it provides a window into the financial health and operational progress of a key player in the cancer treatment services sector. American Shared Hospital Services operates through equipment leasing and direct patient care services, offering turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. The company's performance can serve as a barometer for the broader radiation therapy and stereotactic radiosurgery market.
The company's first quarter results will be closely watched for updates on its Gamma Knife, proton therapy, and advanced radiation therapy cancer treatment services businesses. In its safe harbor statement, the company noted risks including economic conditions, compliance with debt covenants, variability of financial results between quarters, and changes to CMS reimbursement rates. These factors could influence the company's growth trajectory and the expansion of its services.
Investors and analysts will be particularly interested in how the company is managing the integration and continued operation of acquired businesses, as well as its strategy for expanding within or into new markets. The conference call will provide an opportunity for management to address these topics and outline expectations for the remainder of 2026.
To participate in the conference call, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call. A simultaneous webcast can be accessed through the company's website at www.ashs.com or directly via this link. A replay of the call will be available from May 14 through May 21, 2026, by dialing 1-855-669-9658 or 1-412-317-0088, access code 6753554. The replay will also be accessible on the company's website.
The first quarter 2026 financial results press release will be issued before market open on May 14. This earnings report and subsequent call are critical for stakeholders seeking to understand the company's current position and future prospects in the competitive landscape of cancer treatment services.
